-13. - . Healy: (a) The methodology of converting IMP data to pr/hr and then to rads at 1 foot height should be in the July 15 paper. (b) Looks like you are ignoring everything inhaled except the respirable part. Robison: No! We use the entire inhaled material. Healy: A.. (c) Doses from ‘4iPu should be in the dose assessment Robison: These data aren’t available yet from Eberline and DRI. from 241 Puwill Healy: (d) paper. The dose be very small. Ingestion. There are no data in present LLL draft giving pCi/g concentrations for diet (animals, marine). Be sure that in the report you say what you have done and where the data come from. Robison: How do we generalize animal data to other animals? Healy: Would like some discussion of dose models themselves in the dose paper. McClellan: Robison should write a better introduction which includes a general outline of how the dose assessment was done. of detail: (in”mainbody (1) general description There are three levels of how doses were estimated of the report), (2) a very detailed description including equations (in appendix) and (3) worked examples (in appendix). Bai r: You must also give limitations Templeton: You must consider the case of children playing in the dust. Robison: Doesn’t know how to handle estimating Healy: Does Spiers modeling approach for Sr-90 apply to children? and assumptions. doses for this case. *